Point-of-care diagnostic kits for detecting bladder cancer using urine enable screening and surveillance to be carried out at home. We demonstrate a point-of-care diagnostic device with a two-phase system that uses buoyant signal transducers to allow the direct use of untreated urine for screening, providing enhanced accuracy and ease of use over existing methods.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
£14.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 digital issues and online access to articles
£99.00 per year
only £8.25 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Lenis, A. T., Lec, P. M. & Chamie, K. Bladder cancer: a review. JAMA 324, 1980–1991 (2020). A review article summarizing the current clinical status of bladder cancer.
Jordan, B. & Meeks, J. J. T1 bladder cancer: current considerations for diagnosis and management. Nat. Rev. Urol. 16, 23–34 (2019). A review article that presents the clinical criteria for cystectomy in late-stage bladder cancer.
Olislagers, M. et al. Molecular biomarkers of progression in non-muscle-invasive bladder cancer — beyond conventional risk stratification. Nat. Rev. Urol. https://doi.org/10.1038/s41585-024-00914-7 (2024). A review article that presents the necessity of biomarker discovery and systemic clinical validation for early bladder cancer detection.
Todenhöfer, T. et al. Impact of different grades of microscopic hematuria on the performance of urine-based markers for the detection of urothelial carcinoma. Urol. Oncol. 31, 1148–1154 (2013). A paper that presents the impact of haematuria in bladder cancer detection.
Lokeshwar, V. B. et al. Urinary hyaluronic acid and hyaluronidase: markers for bladder cancer detection and evaluation of grade. J. Urol. 163, 348–356 (2000). A paper that presents the clinical evaluation of hyaluronidase as a bladder cancer biomarker.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
This is a summary of: Keum, C. et al. Diagnosis of early-stage bladder cancer via unprocessed urine samples at the point of care. Nat. Biomed. Eng. https://doi.org/10.1038/s41551-024-01298-0 (2024).
Rights and permissions
About this article
Cite this article
A two-phase point-of-care diagnostic device for bladder cancer. Nat. Biomed. Eng (2024). https://doi.org/10.1038/s41551-024-01301-8
Published:
DOI: https://doi.org/10.1038/s41551-024-01301-8